Sign in and upgrade to a paid plan to export futures history as CSV.

Jeevan Scientific Technology Limited

Healthcare · Healthcare Services

BSE: 538837
₹85.18
▲ 4.11 (5.07%)
Sept. 30, 2026 · BSE · bse_bhavcopy
Quality
51/100
Moderate
Valuation
73/100
Undervalued
Momentum
55/100
Neutral

QVM read Cheap on its own multiples Quality Moderate, Valuation Undervalued, Momentum Neutral

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹170 Cr
PE (TTM)
Data unavailable.
Price to Book
2.3
PEG (TTM)
Data unavailable (needs 8 quarters of EPS).
Institutions holding %
Data unavailable.
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
Data unavailable.
Relative return vs Sector, qtr %
72.7
Free Cash Flow
₹-8 Cr
as of March 31, 2026
Industry median ₹1 Cr (75 companies)
EPS Growth (YoY)
100.00%
as of June 30, 2026
Industry median 13.27% (57 companies)
Net Profit Growth (TTM)
196.19%
as of June 30, 2026
Industry median 7.21% (57 companies)
Operating Revenue Growth (TTM)
37.27%
as of June 30, 2026
Industry median 12.82% (57 companies)
Profit Growth (YoY)
181.98%
as of Dec. 31, 2024
Industry median 8.53% (57 companies)
Revenue Growth (YoY)
106.12%
as of June 30, 2026
Industry median 18.84% (52 companies)
Current Ratio
2.51
as of March 31, 2026
Industry median 2.06 (74 companies)
Debt to Equity
0.24
as of March 31, 2026
Industry median 0.11 (62 companies)
Interest Coverage
2.34
as of June 30, 2026
Industry median 7.94 (57 companies)
Net Margin
11.14%
as of June 30, 2026
Industry median 9.88% (61 companies)
Operating Margin (EBIT)
14.62%
as of June 30, 2026
Industry median 17.21% (61 companies)
Operating Margin (TTM)
5.59%
as of June 30, 2026
Industry median 16.20% (59 companies)
Return on Assets
1.35%
as of March 31, 2026
Industry median 5.40% (58 companies)
Return on Capital Employed
-2.12%
as of March 31, 2026
Industry median 10.44% (56 companies)
Return on Equity
1.82%
as of March 31, 2026
Industry median 10.16% (58 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

2 of 6 met
  • No Revenue is higher than a year earlier in each of the last 4 quarters
  • No Quality score is Strong (70 or more)
  • Yes Debt to equity is below 0.5 (0.24)
  • No Return on equity is 15% or more (1.8%)
  • Yes Net cash flow for the latest year is positive
  • No Cash from operations is higher than the year before

Ownership

2 of 2 met
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)

Peer comparison

3 of 3 met
  • Yes 1-year return beats the industry median
  • Yes Revenue growth beats the industry median
  • Yes Profit growth beats the industry median

Value and momentum

3 of 5 met
  • Yes Valuation score is Undervalued (70 or more)
  • No Momentum score is Bullish (70 or more)
  • Yes Price is above the 5, 10 and 20 day averages
  • Yes Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs SENSEX)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
5.1%
Low 78.0100 · High 86.0100
1W return
10.6%
Low 75.0500 · High 86.0100
1M return
18.9%
Low 71.0100 · High 86.0100
52W return
70.0%
Low 70.0000 · High 87.8000
Lifetime High ₹222.7500 (Jan. 11, 2022)
Lifetime Low ₹13.3000 (March 24, 2015)

Full price history and technicals →

EMA & SMA

Bullish6
Bearish0
5D
81.2
10D
80.1
20D
78.6
50D
72.7
100D
66.5
200D
59.1

Delivery and volume

Day avg. delivery
83.8%
Week avg. delivery
78.6%
Month avg. delivery
82.8%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

83.07
Pivot
First resistance88.12
Second resistance91.07
Third resistance96.12
First support80.12
Second support75.07
Third support72.12
Day RSI66.3
Day MFI49.0
Day MACD2.32
Day MACD signal2.49

Beta

1M-0.09
3M0.01
1Y0.01
3Y0.56

Price change analysis

↑ 18.9%
Over 1 Month
LowHigh
71.0186.01
↑ 70.0%
Over 3 Months
LowHigh
70.0087.80
↑ 70.0%
Over 6 Months
LowHigh
70.0087.80
↑ 70.0%
Over 1 Year
LowHigh
70.0087.80
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →

Data unavailable (needs at least 2 historical quarters with both a filed EPS and a matching trading day).

Revenue (June 30, 2026)
₹17 Cr
Net profit (June 30, 2026)
₹2 Cr
Basic EPS (June 30, 2026)
₹0.0000

Ranks #41 of 62 in Healthcare Services by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter30.25%

Largest holders

Data unavailable.

Historical promoter holding

Promoters holdings were unchanged at 30.25% in Jun 2026 qtr

All shareholding details →

DateClientDealActionQuantityPriceExchange
15 Oct 2025 SHEETAL SHARMA Bulk Buy 90,000 52.0000 BSE
15 Oct 2025 RAMPURHAT PSC SLEEPERS LIMITED Bulk Buy 115,000 52.9400 BSE
15 Oct 2025 DURISALA DESAIAH Bulk Sell 500,000 52.1600 BSE
13 Oct 2025 RAMPURHAT PSC SLEEPERS LIMITED Bulk Buy 100,000 49.9700 BSE
13 Oct 2025 AKSHAT JAJODIA Bulk Buy 100,000 50.4800 BSE
13 Oct 2025 PRITY AGARWAL Bulk Buy 300,000 50.3000 BSE
13 Oct 2025 NANDELA GOPALAKRISHNA REDDY Bulk Sell 500,000 50.2000 BSE
30 Jun 2021 VIJAY KUMAR PAHWA Bulk Buy 77,010 90.4600 BSE
22 Jun 2021 ALPHA LEON ENTERPRISES LLP Bulk Sell 86,051 96.3800 BSE
22 Jun 2021 ALPHA LEON ENTERPRISES LLP Bulk Buy 86,051 88.9000 BSE

All bulk and block deals →

Corporate Announcements

All 4 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
1 Oct 2026 Company Update Jeevan Scientific Technology Ltd - 538837 - Closure Of The United States Food And Drug Administration (US FDA) Inspection Of JSTL And Issuance Of The Establishment Inspection Report (EIR), Received By The Company On 30.09.2026 .
29 Sep 2026 Insider Trading / SAST Jeevan Scientific Technology Ltd - 538837 - Closure of Trading Window
25 Sep 2026 AGM/EGM Jeevan Scientific Technology Ltd - 538837 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
25 Sep 2026 AGM/EGM Jeevan Scientific Technology Ltd - 538837 - Shareholder Meeting / Postal Ballot-Outcome of AGM

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • Low financial leverage (Debt/Equity 0.24)
  • Healthy liquidity (Current Ratio 2.51)
  • Strong revenue growth YoY (106.1%)

Weaknesses

  • Low Return on Equity (1.8%)

Opportunities

Data unavailable.

Threats

Data unavailable.

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Jeevan Scientific Technology Limited

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.